Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
17.13
+0.01 (0.06%)
Aug 14, 2025, 11:37 AM - Market open
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts that cover Eton Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $29.67, which forecasts a 73.20% increase in the stock price over the next year. The lowest target is $26 and the highest is $35.
Price Target: $29.67 (+73.20%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 29, 2025.
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | +104.32% | May 29, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $24 → $26 | Strong Buy | Reiterates | $24 → $26 | +51.78% | May 16, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $26 → $28 | Strong Buy | Maintains | $26 → $28 | +63.46% | May 14, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | +51.78% | Mar 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $24 | Strong Buy | Reiterates | $21 → $24 | +40.11% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
78.46M
from 39.01M
Increased by 101.12%
Revenue Next Year
114.32M
from 78.46M
Increased by 45.71%
EPS This Year
0.28
from -0.15
EPS Next Year
1.31
from 0.28
Increased by 362.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 83.5M | 128.0M | 183.0M | ||
| Avg | 78.5M | 114.3M | 159.9M | ||
| Low | 72.9M | 104.8M | 136.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 114.1% | 63.1% | 60.1% | ||
| Avg | 101.1% | 45.7% | 39.8% | ||
| Low | 86.9% | 33.6% | 19.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.62 | 1.76 | 2.01 | ||
| Avg | 0.28 | 1.31 | 1.94 | ||
| Low | -0.06 | 0.72 | 1.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 525.1% | 53.6% | ||
| Avg | - | 362.6% | 48.8% | ||
| Low | - | 153.5% | 42.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.